[go: up one dir, main page]

DE59405654D1 - T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen - Google Patents

T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen

Info

Publication number
DE59405654D1
DE59405654D1 DE59405654T DE59405654T DE59405654D1 DE 59405654 D1 DE59405654 D1 DE 59405654D1 DE 59405654 T DE59405654 T DE 59405654T DE 59405654 T DE59405654 T DE 59405654T DE 59405654 D1 DE59405654 D1 DE 59405654D1
Authority
DE
Germany
Prior art keywords
lymphocyte
infections
treatment
pharmaceutical composition
containing pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE59405654T
Other languages
English (en)
Inventor
Bernhard Heising
Edelgard Heising
Franziska Heising
Cathrin Heising
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/EP1994/002313 external-priority patent/WO1995003812A1/de
Application granted granted Critical
Publication of DE59405654D1 publication Critical patent/DE59405654D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/45—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE59405654T 1993-07-29 1994-07-13 T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen Expired - Fee Related DE59405654D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4325959 1993-07-29
DE4422020A DE4422020A1 (de) 1993-07-29 1994-06-16 Pharmazeutische Zusammensetzung
PCT/EP1994/002313 WO1995003812A1 (de) 1993-07-29 1994-07-13 T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen

Publications (1)

Publication Number Publication Date
DE59405654D1 true DE59405654D1 (de) 1998-05-14

Family

ID=6494314

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4422020A Withdrawn DE4422020A1 (de) 1993-07-29 1994-06-16 Pharmazeutische Zusammensetzung
DE59405654T Expired - Fee Related DE59405654D1 (de) 1993-07-29 1994-07-13 T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4422020A Withdrawn DE4422020A1 (de) 1993-07-29 1994-06-16 Pharmazeutische Zusammensetzung

Country Status (1)

Country Link
DE (2) DE4422020A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256588A (en) * 1979-11-02 1981-03-17 E. I. Du Pont De Nemours And Company Separation and recovery of B and T lymphocytes
JPS5936963B2 (ja) * 1981-03-10 1984-09-06 旭化成株式会社 Ｔ細胞分離材および分離方法
JPS60231613A (ja) * 1984-04-28 1985-11-18 Terumo Corp Ｔ細胞とｂ細胞の分離方法およびその分離材ならびにその分離装置
US5106746A (en) * 1985-05-22 1992-04-21 E. I. Du Pont De Nemours And Company Process for the in vitro immunization of human splenocytes against tumor associated antigens
ATE107861T1 (de) * 1986-09-19 1994-07-15 Oncogen Verwendung von aktivierten t-lymphozyten zur vorbereitung einer pharmazeutischen zusammensetzung zur behandlung von aids.
WO1992020783A1 (de) * 1991-05-16 1992-11-26 Idt Ag Für In Vivo Diagnostik Und Therapie Verfahren zur bereitstellung von antigen-spezifischen b- und t-lymphozyten sowie davon erhaltene monoklonale antikörper

Also Published As

Publication number Publication date
DE4422020A1 (de) 1995-02-02

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE69332732D1 (de) Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose
DE69412552D1 (de) Medizinisches Instrument zur Behandlung von Sinusitis
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
DE69710095D1 (de) Pharmazeutische zubereitung zur behandlung von diabetes
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
BR9407799A (pt) Composição de matéria método de tratamento e composição farmaceutica
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
DE69631157D1 (de) Pharmazeutische Zubereitung zur Verwendung in der Behandlung von Diabetes
DE4497905T1 (de) Pharmazeutische Zusammensetzung zur Prävention und Behandlung des Motion-Sickness-Syndroms
FI895064A7 (fi) Syklosporiinia sisältäviä koostumuksia silmätulehdusten hoitoon
DE3884200D1 (de) Verfahren zur Behandlung von Mastitis und anderen Staphylokokkeninfektionen.
FI951306A0 (fi) Otsoniystävällinen sterilointiaineseos
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE4495520T1 (de) Verfahren und pharmazeutische Zusammensetzung zum zielgerichten Anwenden von Wirkstoffen
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
NO982562D0 (no) Sammensetning for behandling av smerte
BR9610851A (pt) Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8321 Willingness to grant licences paragraph 23 withdrawn
8320 Willingness to grant licences declared (paragraph 23)
8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted
8339 Ceased/non-payment of the annual fee